Flagship Harbor Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-124	Closed	-$3.31K	–	740
2025 Q4	$3.31K	Buy	+124	New	+$2.96K	﹤0.01%	1744
2020 Q4	–	Sell	-1,148	Closed	-$47K	–	569
2020 Q3	$47K	Buy	1,148 +14	+1%	+$605	0.01%	871
2020 Q2	$54K	Hold	1,134	–	–	0.01%	831
2020 Q1	$48K	Hold	1,134	–	–	0.01%	760
2019 Q4	$49K	Hold	1,134	–	–	0.01%	810
2019 Q3	$40K	Hold	1,134	–	–	0.01%	839
2019 Q2	$30K	Sell	1,134 -7,000	-86%	-$179K	0.01%	917
2019 Q1	$218K	Hold	8,134	–	–	0.04%	380
2018 Q4	$131K	Sell	8,134 -3,000	-27%	-$58.3K	0.03%	460
2018 Q3	$231K	Sell	11,134 -650	-6%	-$10.2K	0.04%	378
2018 Q2	$179K	Buy	+11,784	New	+$210K	0.04%	426
2017 Q4	–	Sell	-6,884	Closed	-$260K	–	371
2017 Q3	$260K	Buy	+6,884	New	+$224K	0.08%	265
2017 Q2	–	Sell	-6,234	Closed	-$202K	–	344
2017 Q1	$202K	Buy	+6,234	New	+$220K	0.08%	300